病毒血症水平较低的HIV感染患者前病毒DNA中的耐药性突变 - Suppr

Drug resistance mutations in proviral DNA of HIV-infected patients with low level of viremia.

作者信息

Villalobos Camila, Ceballos María Elena, Ferrés Marcela, Palma Carlos

机构信息

Infectious Diseases Department, Escuela de Medicina, Pontificia Universidad Católica de Chile, Chile; Infectious Diseases Service, Hospital Naval Almirante Nef, Chile.

Infectious Diseases Department, Escuela de Medicina, Pontificia Universidad Católica de Chile, Chile.

出版信息

J Clin Virol. 2020 Nov;132:104657. doi: 10.1016/j.jcv.2020.104657. Epub 2020 Oct 7.

DOI:10.1016/j.jcv.2020.104657

PMID:33049643

Abstract

摘要

相似文献

Drug resistance mutations in proviral DNA of HIV-infected patients with low level of viremia.病毒血症水平较低的HIV感染患者前病毒DNA中的耐药性突变

J Clin Virol. 2020 Nov;132:104657. doi: 10.1016/j.jcv.2020.104657. Epub 2020 Oct 7.

Proviral DNA as a Target for HIV-1 Resistance Analysis.作为HIV-1耐药性分析靶点的前病毒DNA

Intervirology. 2015;58(3):184-9. doi: 10.1159/000431093. Epub 2015 Jun 27.

HIV-1C proviral DNA for detection of drug resistance mutations.HIV-1C 前病毒 DNA 用于检测耐药突变。

PLoS One. 2018 Oct 4;13(10):e0205119. doi: 10.1371/journal.pone.0205119. eCollection 2018.

New Aspects of the Virus Life Cycle and Clinical Utility of Next Generation Sequencing based HIV-1 Resistance Testing in the Genomic, the Proviral, and the Viral Reservoir of Peripheral Blood Mononuclear Cells.新一代测序在病毒基因组、前病毒和外周血单核细胞病毒库中检测 HIV-1 耐药性的病毒生活周期的新方面和临床应用。

Curr HIV Res. 2022;20(3):213-221. doi: 10.2174/1570162X20666220324111418.

Distinctive Drug-resistant Mutation Profiles and Interpretations of HIV-1 Proviral DNA Revealed by Deep Sequencing in Reverse Transcriptase.通过逆转录酶深度测序揭示的HIV-1前病毒DNA独特的耐药性突变谱及解读

Biomed Environ Sci. 2016 Apr;29(4):239-47. doi: 10.3967/bes2016.031.

Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.在接受高效抗逆转录病毒治疗（HAART）且病毒血症低于1000拷贝/毫升的患者循环CD4(+) T细胞中检测和定量原病毒HIV-1 184 M/V 。

J Clin Virol. 2005 Dec;34(4):257-67. doi: 10.1016/j.jcv.2005.02.015. Epub 2005 Apr 18.

Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.接受高效抗逆转录病毒治疗（HAART）失败的HIV-1感染患者血浆RNA和全血DNA中的抗逆转录病毒基因型耐药性

J Med Virol. 2008 Oct;80(10):1695-706. doi: 10.1002/jmv.21261.

HIV drug resistance mutations in proviral DNA from a community treatment program.来自社区治疗项目的前病毒DNA中的HIV耐药性突变

PLoS One. 2015 Jan 30;10(1):e0117430. doi: 10.1371/journal.pone.0117430. eCollection 2015.

Dynamics of 103K/N and 184M/V HIV-1 drug resistant populations: relative comparison in plasma virus RNA versus CD45RO+T cell proviral DNA.103K/N和184M/V HIV-1耐药群体的动态变化：血浆病毒RNA与CD45RO+T细胞前病毒DNA的相对比较

J Clin Virol. 2007 Jul;39(3):215-21. doi: 10.1016/j.jcv.2007.04.014. Epub 2007 May 30.

Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.尽管病毒发生了进化且耐药基因型的选择非常有限，但高效抗逆转录病毒疗法仍能长期抑制血浆病毒血症。

J Med Virol. 2004 Jul;73(3):350-61. doi: 10.1002/jmv.20098.

引用本文的文献

A Guide to the Evolving Clinical Landscape of Low-Level Viremia Among Persons with HIV in the Modern Treatment Era.现代治疗时代HIV感染者低水平病毒血症不断演变的临床状况指南

Curr HIV/AIDS Rep. 2025 Jun 26;22(1):39. doi: 10.1007/s11904-025-00743-2.

Factors affecting viral suppression or rebound in people living with HIV and receiving antiretroviral therapy in Ghana.影响加纳接受抗逆转录病毒治疗的艾滋病毒感染者病毒抑制或反弹的因素。

Front Public Health. 2025 Mar 19;13:1508793. doi: 10.3389/fpubh.2025.1508793. eCollection 2025.

Archived HIV-1 Drug Resistance Mutations: Role of Proviral HIV-1 DNA Genotype for the Management of Virological Responder People Living with HIV.已归档的 HIV-1 耐药突变：前病毒 HIV-1 DNA 基因型在管理 HIV 病毒学应答者中的作用。

Viruses. 2024 Oct 30;16(11):1697. doi: 10.3390/v16111697.

Risk factors and clinical prediction models for low-level viremia in people living with HIV receiving antiretroviral therapy: an 11-year retrospective study.接受抗逆转录病毒治疗的HIV感染者低水平病毒血症的危险因素及临床预测模型：一项11年的回顾性研究

Front Microbiol. 2024 Nov 1;15:1451201. doi: 10.3389/fmicb.2024.1451201. eCollection 2024.

Characteristics of drug resistance mutations in ART-experienced HIV-1 patients with low-level viremia in Zhengzhou City, China.中国郑州市 ART 经验丰富的 HIV-1 低病毒血症患者耐药突变特征。

Sci Rep. 2024 May 9;14(1):10620. doi: 10.1038/s41598-024-60965-z.

Influencing factors and adverse outcomes of virologic rebound states in anti-retroviral-treated individuals with HIV infection.接受抗逆转录病毒治疗的HIV感染者病毒学反弹状态的影响因素及不良后果

J Virus Erad. 2023 Mar 4;9(1):100320. doi: 10.1016/j.jve.2023.100320. eCollection 2023 Mar.

HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads.用于检测低病毒载量样本中耐药性突变的HIV-1C内部基于RNA的基因分型检测方法

Infect Drug Resist. 2022 Dec 22;15:7565-7576. doi: 10.2147/IDR.S388816. eCollection 2022.

Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells.外周血单个核细胞中 HIV-1 DNA 的基因型耐药性检测。

Clin Microbiol Rev. 2022 Dec 21;35(4):e0005222. doi: 10.1128/cmr.00052-22. Epub 2022 Sep 14.

Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort.抗逆转录病毒治疗期间低水平病毒血症和病毒学突破后的病毒学失败：来自欧洲多中心队列的结果。

Clin Infect Dis. 2023 Jan 6;76(1):25-31. doi: 10.1093/cid/ciac762.

HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.博茨瓦纳在接受联合抗逆转录病毒治疗（ART）时低病毒血症个体中的 HIV-1 耐药突变。

J Antimicrob Chemother. 2022 Apr 27;77(5):1385-1395. doi: 10.1093/jac/dkac056.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Drug resistance mutations in proviral DNA of HIV-infected patients with low level of viremia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献